Healthcare Sector Review: Winning and Losing Stocks on Nov 14th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Bio-Reference (NASDAQ:BRLI): The shares closed at $13.06, up $0.75, or 6.09%, on the day. Its market capitalization is $365.03 million. About the company: Bio-Reference Laboratories, Inc. operates an independent clinical laboratory in the Northeast United States. The Company’s laboratory has specialty capability in the areas of genomics, oncology, correctional health, and complimentary medicine. Bio-Reference also offers information solutions for reducing healthcare costs and improving quality performance. Get the most recent company news and stock data here >>
  • Lannett Company, Inc. (NYSE:LCI): The shares closed at $4.04, up $0.22, or 5.76%, on the day. Its market capitalization is $114.63 million. About the company: Lannett Company, Inc. manufactures and distributes pharmaceutical products under its own trade name and under generic names. The Company also distributes competitive pharmaceutical products manufactured by other companies. The principal products include antifungals, antacids, dermatological preparations, and analgesic sedatives. Get the most recent company news and stock data here >>
  • MELA Sciences, Inc. (NASDAQ:MELA): The shares closed at $5.25, up $0.27, or 5.42%, on the day. Its market capitalization is $132.63 million. About the company: MELA Sciences Inc is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company’s product features a device that captures images of suspicious pigmented skin lesions and extracts data. Get the most recent company news and stock data here >>
  • (): The shares closed at $52.92, up $2.51, or 4.98%, on the day. Its market capitalization is $130.57 million. Get the most recent company news and stock data here >>
  • Amylin Pharmaceuticals (NASDAQ:AMLN): The shares closed at $10.45, up $0.43, or 4.29%, on the day. Its market capitalization is $1.53 billion. About the company: Amylin Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for diabetes and obesity. The Company’s marketed products include treatments for adults with type 1 and type 2 diabetes. Get the most recent company news and stock data here >>

Losers (% price change)

  • Cadence Pharmaceuticals (NASDAQ:CADX): The shares closed at $3.97, down $1.09, or 21.54%, on the day. Its market capitalization is $252.55 million. About the company: Cadence Pharmaceuticals Inc. is a biopharmaceutical company that develops drugs for use in hospitals. The Company produces intravenous APAP for the treatment of acute pain and fever, and omiganan for the prevention of intravascular catheter-related infections. Get the most recent company news and stock data here >>
  • SIGA Technologies, Inc. (NASDAQ:SIGA): The shares closed at $2.66, down $0.3, or 10.14%, on the day. Its market capitalization is $136.77 million. About the company: SIGA Technologies, Inc. explores, develops, and markets products for use in defense against biological warfare agents. The Company’s also offers products such as novel anti-infectives or the prevention and treatment of serious infectious diseases. Get the most recent company news and stock data here >>
  • Salix Pharmaceuticals (NASDAQ:SLXP): The shares closed at $33.85, down $3.66, or 9.76%, on the day. Its market capitalization is $2.00 billion. About the company: Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force. Get the most recent company news and stock data here >>
  • Amedisys, Inc. (NASDAQ:AMED): The shares closed at $11.57, down $0.96, or 7.66%, on the day. Its market capitalization is $347.44 million. About the company: Amedisys, Inc. is a multi-regional provider of alternate-site health care services. The Company offers home health care nursing, home infusion therapy, and ambulatory surgery centers. Amedisys operates offices within a network of subsidiaries in the southern and southeastern United States. Get the most recent company news and stock data here >>
  • Flamel Tech. S.A. (NASDAQ:FLML): The shares closed at $4.56, down $0.36, or 7.32%, on the day. Its market capitalization is $111.00 million. About the company: Flamel Technologies S.A. develops polymer technologies for applications such as drug delivery, biomaterials, and agrochemicals. The Company’s programs include “Micropump” and “Medusa” in drug delivery, and “ColCys” in biomaterial-based medical devices. Flamel builds on its technology platforms to develop other products, such as new materials for opthalmic lens products. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>